Sign in

CIK 0000034956 · Non-accelerated filer<br>Smaller reporting company

TENAX THERAPEUTICS, INC.

Sign in to watch
Ticker
TENX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
262593535
Phone
919-855-2100
Business address
101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL, NC, 27517
Former names
OXYGEN BIOTHERAPEUTICS, INC., SYNTHETIC BLOOD INTERNATIONAL INC
  1. 4 Open-market buy 10% owner bought 922,849 shares at an average $1.59 ($1,463,426)
  2. 4 Open-market buy Director bought 53,000 shares at $1.92 ($101,760)
  3. 4 Open-market buy CEO bought 10,850 shares at an average $1.85 ($20,087)
  4. 4 Open-market buy Chief Financial Officer bought 5,675 shares at $1.94 ($10,981)
  5. 4 Open-market buy 10% owner bought 900,000 shares at $1.78 ($1,604,160)
  6. 4 Open-market buy 10% owner bought 770,333 shares at an average $1.79 ($1,381,750)
  7. 4 Open-market buy 10% owner bought 1,025,867 shares at an average $1.77 ($1,814,147)
  8. 3 Insider Initial Statement of Ownership
  9. 4 Option exercise CEO acquired 8,719 shares (option exercise)
  10. 4 Grant or award Chief Financial Officer acquired 10,000 shares (grant or award)
  11. 3 Insider Initial Statement of Ownership
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Open-market buy Chief Medical Officer bought 5,000 shares at an average $10.16 ($50,793)

Page 1 of 11 · 206 filings